↓ Skip to main content

Daunorubicinの白血病患者における体内動態

Overview of attention for article published in CHEMOTHERAPY, August 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

wikipedia
1 Wikipedia page
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Daunorubicinの白血病患者における体内動態
Published in
CHEMOTHERAPY, August 2011
DOI 10.11250/chemotherapy1953.35.398
Authors

小川 浩司, 松崎 道男, 宮下 裕子, 本村 茂樹, 伊藤 章, 大久保 隆男, 丸田 壱郎, 児玉 文雄

Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2021.
All research outputs
#8,731,423
of 25,852,155 outputs
Outputs from CHEMOTHERAPY
#13
of 29 outputs
Outputs of similar age
#47,443
of 131,682 outputs
Outputs of similar age from CHEMOTHERAPY
#2
of 9 outputs
Altmetric has tracked 25,852,155 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 29 research outputs from this source. They receive a mean Attention Score of 3.5. This one scored the same or higher as 16 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 131,682 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.